Medical Developments International (MVP.AX) Earnings Analysis

Medical Developments International (MVP.AX) next reports earnings on 2026-08-20, consensus EPS -0.005 AUD. Last quarter (2026-02-18) it beat with EPS -0.002 AUD vs -0.014 AUD est (+85.7%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E -100.00.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does MVP.AX next report earnings?

Next earnings date2026-08-20
Consensus EPS estimate-0.005 AUD
Revenue estimate0.02B

MVP.AX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-18-0.002 AUD-0.014 AUD+85.7%Beat
2025-02-190.0027 AUD-0.018 AUD+115%Beat
2024-08-26-0.33912 AUD-0.203 AUD-67.1%Miss

Beat rate: 2/3 (67%) over reported quarters with consensus data.

MVP.AX valuation and analyst view

Trailing P/E-100.00
Trailing EPS-0.00387 AUD
Price / book0.80
Dividend yield0.00%
Market cap0.04B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Medical Developments International (MVP.AX)'s next earnings date?

Medical Developments International is next scheduled to report on 2026-08-20, with a consensus EPS estimate of -0.005 AUD and revenue estimate of 0.02B.

Did MVP.AX beat earnings last quarter?

In its 2026-02-18 report, MVP.AX posted EPS of -0.002 AUD versus a -0.014 AUD estimate — a beat of 85.7%.

What is MVP.AX's earnings track record?

Over the last 3 reported quarters with consensus data, MVP.AX beat estimates 2 times (67%).

What is MVP.AX's current P/E ratio and EPS?

MVP.AX trades at a trailing P/E of -100.00 on trailing EPS of -0.003870109056477709 AUD.

What do analysts rate MVP.AX?

MVP.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.